Connection

MICHAEL BRAUN to Female

This is a "connection" page, showing publications MICHAEL BRAUN has written about Female.
Connection Strength

0.546
  1. Fetal Nephrology: A Quaternary Care Center Experience. Kidney360. 2023 03 01; 4(3):333-340.
    View in: PubMed
    Score: 0.030
  2. Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report. BMC Nephrol. 2017 Jul 18; 18(1):243.
    View in: PubMed
    Score: 0.020
  3. Defining and predicting 'intrauterine fetal renal failure' in congenital lower urinary tract obstruction. Pediatr Nephrol. 2016 Apr; 31(4):605-12.
    View in: PubMed
    Score: 0.018
  4. Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2034-40.
    View in: PubMed
    Score: 0.013
  5. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Am J Kidney Dis. 2011 Feb; 57(2):291-9.
    View in: PubMed
    Score: 0.013
  6. Urine proteome analysis in murine nephrotoxic serum nephritis. Am J Nephrol. 2009; 30(5):450-8.
    View in: PubMed
    Score: 0.012
  7. Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol. Clin Exp Med. 2026 Jan 21; 26(1):118.
    View in: PubMed
    Score: 0.009
  8. Exploring perceptual disparities: A study on the level of understanding of colorectal cancer care among patients and healthcare professionals. Int J Colorectal Dis. 2026 Jan 08; 41(1):22.
    View in: PubMed
    Score: 0.009
  9. Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial. Clin Cancer Res. 2026 Jan 06; 32(1):214-223.
    View in: PubMed
    Score: 0.009
  10. A clinical rule-based indicator to identify recurrence of colorectal cancer after curative resection using linked routinely collected national data. Cancer Epidemiol. 2026 Feb; 100:102962.
    View in: PubMed
    Score: 0.009
  11. Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN Study. Clin Colorectal Cancer. 2026 03; 25(1):115-124.
    View in: PubMed
    Score: 0.009
  12. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J Am Soc Nephrol. 2005 Dec; 16(12):3572-82.
    View in: PubMed
    Score: 0.009
  13. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. J Am Soc Nephrol. 2005 Jul; 16(7):2225-33.
    View in: PubMed
    Score: 0.009
  14. Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial. Lancet Oncol. 2025 May; 26(5):629-640.
    View in: PubMed
    Score: 0.009
  15. Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial. Mol Cancer. 2025 Mar 26; 24(1):96.
    View in: PubMed
    Score: 0.009
  16. Value of hospital administrative data linked to national cancer registry records to identify metastatic disease at time of primary diagnosis in colorectal cancer patients: a study using national data in England. BMC Cancer. 2025 Mar 06; 25(1):407.
    View in: PubMed
    Score: 0.009
  17. HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN. Breast Cancer Res. 2025 Feb 14; 27(1):22.
    View in: PubMed
    Score: 0.008
  18. Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2025 02 03; 8(2):e2461639.
    View in: PubMed
    Score: 0.008
  19. Oncological Outcomes From Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases. Clin Colorectal Cancer. 2025 06; 24(2):166-179.
    View in: PubMed
    Score: 0.008
  20. Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM. Curr Oncol. 2024 12 11; 31(12):7903-7913.
    View in: PubMed
    Score: 0.008
  21. Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer center. Oncologist. 2024 12 06; 29(12):e1680-e1691.
    View in: PubMed
    Score: 0.008
  22. Fetal bladder morphology as a predictor of outcome in fetal lower urinary tract obstruction. Prenat Diagn. 2024 02; 44(2):124-130.
    View in: PubMed
    Score: 0.007
  23. De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial. J Clin Oncol. 2023 08 01; 41(22):3796-3804.
    View in: PubMed
    Score: 0.007
  24. Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial. Clin Cancer Res. 2023 02 16; 29(4):805-814.
    View in: PubMed
    Score: 0.007
  25. Association of Quality and Technology With Patient Mobility for Colorectal Cancer Surgery. JAMA Surg. 2023 01 01; 158(1):e225461.
    View in: PubMed
    Score: 0.007
  26. Genetic diagnosis and renal biopsy findings in the setting of a renal genetics clinic. Am J Med Genet C Semin Med Genet. 2022 09; 190(3):302-308.
    View in: PubMed
    Score: 0.007
  27. Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial. Breast Cancer Res. 2022 09 02; 24(1):58.
    View in: PubMed
    Score: 0.007
  28. Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer. J Clin Oncol. 2022 08 10; 40(23):2557-2567.
    View in: PubMed
    Score: 0.007
  29. De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 2022 05; 23(5):625-635.
    View in: PubMed
    Score: 0.007
  30. Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer. Clin Colorectal Cancer. 2022 06; 21(2):e117-e125.
    View in: PubMed
    Score: 0.007
  31. TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer Med. 2021 12; 10(23):8581-8594.
    View in: PubMed
    Score: 0.007
  32. Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring. J Clin Oncol. 2021 11 20; 39(33):3705-3715.
    View in: PubMed
    Score: 0.007
  33. The effect of continuous venovenous hemodiafiltration on amino acid delivery, clearance, and removal in children. Pediatr Nephrol. 2022 02; 37(2):433-441.
    View in: PubMed
    Score: 0.007
  34. The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials. Breast. 2021 Oct; 59:58-66.
    View in: PubMed
    Score: 0.007
  35. Novel scoring system for determining fetal candidacy for prenatal intervention for severe congenital lower urinary tract obstruction. Eur J Obstet Gynecol Reprod Biol. 2021 Jul; 262:118-123.
    View in: PubMed
    Score: 0.007
  36. Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial. J Immunother Cancer. 2021 05; 9(5).
    View in: PubMed
    Score: 0.007
  37. Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials. Breast Cancer Res. 2021 03 18; 23(1):36.
    View in: PubMed
    Score: 0.006
  38. The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic. Clin Colorectal Cancer. 2021 06; 20(2):e120-e128.
    View in: PubMed
    Score: 0.006
  39. Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation. Clin Cancer Res. 2021 02 15; 27(4):1119-1130.
    View in: PubMed
    Score: 0.006
  40. Natural genetic variation in Stim1 creates stroke in the spontaneously hypertensive rat. Genes Immun. 2020 05; 21(3):182-192.
    View in: PubMed
    Score: 0.006
  41. Neurodevelopmental Outcome in Infants with Lower Urinary Tract Obstruction Based on Different Degrees of Severity. Fetal Diagn Ther. 2020; 47(8):587-596.
    View in: PubMed
    Score: 0.006
  42. Nephronophthisis due to a novel DCDC2 variant in a patient from African-Caribbean descent: A case report. Am J Med Genet A. 2020 03; 182(3):527-531.
    View in: PubMed
    Score: 0.006
  43. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen. Am J Kidney Dis. 1999 Dec; 34(6):1022-32.
    View in: PubMed
    Score: 0.006
  44. Characterization of the renal phenotype in RMND1-related mitochondrial disease. Mol Genet Genomic Med. 2019 12; 7(12):e973.
    View in: PubMed
    Score: 0.006
  45. Outcome of fetuses with lower urinary tract obstruction and normal amniotic fluid volume in second trimester of pregnancy. Ultrasound Obstet Gynecol. 2019 Oct; 54(4):500-505.
    View in: PubMed
    Score: 0.006
  46. Functional Outcome Following Stroke Thrombectomy in Clinical Practice. Stroke. 2019 09; 50(9):2500-2506.
    View in: PubMed
    Score: 0.006
  47. Role of Emergency Laparoscopic Colectomy for Colorectal Cancer: A Population-based Study in England. Ann Surg. 2019 07; 270(1):172-179.
    View in: PubMed
    Score: 0.006
  48. Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial. Int J Cancer. 2020 01 01; 146(1):262-271.
    View in: PubMed
    Score: 0.006
  49. Health-related quality of life in glomerular disease. Kidney Int. 2019 05; 95(5):1209-1224.
    View in: PubMed
    Score: 0.006
  50. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. Am J Kidney Dis. 2019 02; 73(2):218-229.
    View in: PubMed
    Score: 0.006
  51. Systematic evaluation of stroke thrombectomy in clinical practice: The German Stroke Registry Endovascular Treatment. Int J Stroke. 2019 06; 14(4):372-380.
    View in: PubMed
    Score: 0.005
  52. Peritoneal dialysis catheter outcomes in infants initiating peritoneal dialysis for end-stage renal disease. BMC Nephrol. 2018 09 14; 19(1):231.
    View in: PubMed
    Score: 0.005
  53. Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy. Radiother Oncol. 2019 02; 131:202-207.
    View in: PubMed
    Score: 0.005
  54. Surgical interventions and anesthesia in the 1st year of life for lower urinary tract obstruction. J Pediatr Surg. 2019 Apr; 54(4):820-824.
    View in: PubMed
    Score: 0.005
  55. Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results. J Natl Cancer Inst. 2018 06 01; 110(6):628-637.
    View in: PubMed
    Score: 0.005
  56. Effect of public reporting of surgeons' outcomes on patient selection, "gaming," and mortality in colorectal cancer surgery in England: population based cohort study. BMJ. 2018 May 02; 361:k1581.
    View in: PubMed
    Score: 0.005
  57. Therapeutic Plasma Exchange Use in Pediatric Neurologic Disorders at a Tertiary Care Center: A 10-Year Review. J Child Neurol. 2018 02; 33(2):140-145.
    View in: PubMed
    Score: 0.005
  58. Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients. J Natl Cancer Inst. 2017 10 01; 109(10).
    View in: PubMed
    Score: 0.005
  59. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. PLoS One. 2017; 12(8):e0182134.
    View in: PubMed
    Score: 0.005
  60. Lower urinary tract obstruction: fetal intervention based on prenatal staging. Pediatr Nephrol. 2017 10; 32(10):1871-1878.
    View in: PubMed
    Score: 0.005
  61. De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET. J Clin Oncol. 2017 Sep 10; 35(26):3046-3054.
    View in: PubMed
    Score: 0.005
  62. Are ultrasound renal aspects associated with urinary biochemistry in fetuses with lower urinary tract obstruction? Prenat Diagn. 2016 Dec; 36(13):1206-1210.
    View in: PubMed
    Score: 0.005
  63. Fetal lower urinary tract obstruction: proposal for standardized multidisciplinary prenatal management based on disease severity. Ultrasound Obstet Gynecol. 2016 Oct; 48(4):476-482.
    View in: PubMed
    Score: 0.005
  64. Whole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene. Genet Med. 2017 04; 19(4):412-420.
    View in: PubMed
    Score: 0.005
  65. Factors associated with fetal shunt dislodgement in lower urinary tract obstruction. Prenat Diagn. 2016 Aug; 36(8):720-5.
    View in: PubMed
    Score: 0.005
  66. Nephrotic syndrome accompanying familial hemophagocytic syndrome. J Pediatr Hematol Oncol. 1996 May; 18(2):195-7.
    View in: PubMed
    Score: 0.005
  67. Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet. 2016 07; 53(7):465-71.
    View in: PubMed
    Score: 0.005
  68. Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study. Psychooncology. 2017 01; 26(1):74-80.
    View in: PubMed
    Score: 0.005
  69. The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant. Am J Kidney Dis. 2015 Dec; 66(6):1105-6.
    View in: PubMed
    Score: 0.004
  70. Who may benefit from preoperative breast MRI? A single-center analysis of 1102 consecutive patients with primary breast cancer. Breast Cancer Res Treat. 2015 Oct; 153(3):531-7.
    View in: PubMed
    Score: 0.004
  71. Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.004
  72. Using a non-invasive method in chronic hemodialysis pediatric patients to estimate hemoglobin. Pediatr Nephrol. 2015 Apr; 30(4):661-4.
    View in: PubMed
    Score: 0.004
  73. Immunoglobulin locus associates with serum IgG levels and albuminuria. J Am Soc Nephrol. 2011 May; 22(5):881-9.
    View in: PubMed
    Score: 0.003
  74. Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. J Exp Med. 2009 Jun 08; 206(6):1227-35.
    View in: PubMed
    Score: 0.003
  75. Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. Am J Hypertens. 2008 May; 21(5):533-8.
    View in: PubMed
    Score: 0.003
  76. Cryptococcosis associated with crescentic glomerulonephritis. Pediatr Nephrol. 2008 May; 23(5):827-30.
    View in: PubMed
    Score: 0.003
  77. Pediatric hypertension: diagnosis, evaluation, management, and treatment for the primary care physician. Curr Probl Pediatr Adolesc Health Care. 2005 Aug; 35(7):262-94.
    View in: PubMed
    Score: 0.002
  78. Anti-mouse mesangial cell serum induces acute glomerulonephropathy in mice. Nephron Exp Nephrol. 2003; 93(3):e92-106.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.